XN05, a novel synthesized microtubule inhibitor, exhibits potent activity against human carcinoma cells in vitro

Cancer Lett. 2009 Nov 18;285(1):13-22. doi: 10.1016/j.canlet.2009.04.042. Epub 2009 Aug 3.

Abstract

The present data showed that a novel synthesized compound, N-acetyl-N-(4-(4-methoxyphenyl-3-(3,4,5-trimethoxyphenyl)isoxazol-5-yl)acetamide (XN05), exhibited potent antitumor activity against various cancer cells in vitro. XN05-treatment in human hepatocellular carcinoma cells resulted in the accumulation of G2/M phase cells and finally induced apoptosis assessed by flow cytometry analysis. Western blot and immunofluorescence experiments indicated that XN05 depolymerized microtubules similar to the effect of combretastatin-A4. In addition, XN05-treatment influenced the expression of cell cycle and apoptosis related proteins in BEL-7402 cells, which was associated with the appearance of phosphorylated Bcl-2. Taken together, all the data demonstrated that XN05 exhibited its antitumor activity through disrupting the microtubule assembly, causing cell cycle arrest and consequently inducing apoptosis in BEL-7402 cells. Therefore, the novel compound XN05 is a promising microtubule inhibitor that has great potentials for therapeutic treatment of various malignancies.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetamides / chemical synthesis
  • Acetamides / pharmacology*
  • Apoptosis / drug effects
  • Carcinoma, Hepatocellular / metabolism
  • Carcinoma, Hepatocellular / pathology*
  • Caspases / metabolism
  • Cell Cycle / drug effects
  • Cell Cycle Proteins / metabolism
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Dose-Response Relationship, Drug
  • Enzyme Activation
  • Humans
  • Inhibitory Concentration 50
  • Isoxazoles / chemical synthesis
  • Isoxazoles / pharmacology*
  • Liver Neoplasms / metabolism
  • Liver Neoplasms / pathology*
  • Microtubules / drug effects*
  • Microtubules / metabolism
  • Microtubules / pathology
  • Phosphorylation
  • Protein Multimerization
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Stilbenes / pharmacology
  • Time Factors
  • Tubulin / metabolism*
  • Tubulin Modulators / chemical synthesis
  • Tubulin Modulators / pharmacology*

Substances

  • Acetamides
  • Cell Cycle Proteins
  • Isoxazoles
  • N-acetyl-N-(4-(4-methoxyphenyl-3-(3,4,5-trimethoxyphenyl)isoxazol-5-yl)acetamide)
  • Proto-Oncogene Proteins c-bcl-2
  • Stilbenes
  • Tubulin
  • Tubulin Modulators
  • Caspases
  • fosbretabulin